PDA Letter Article

Industry Eyes Future of Visual Inspection

by John Shabushnig, PhD, Insight Pharma Consulting; Markus Lankers, PhD, MIBIC; John Ayres, MD, Pharma Safety Solutions; Roy Cherris, Bridge Associates; Robert Miller, Pfizer; Romain Veillon, GSK Vaccines; and Rick Watson, Merck

Photo courtesy of Antares Vision. This photo depicts the company’s Visual Rotating Inspector machine.

Five Critical Areas of Concern Draw Attention of Pharma Industry

It goes without saying that visual inspection is critical to parenteral manufacturing. All units produced must be inspected to ensure a high level of quality assurance. Visual inspection can be performed with the human eye by a trained inspector under controlled conditions or via automation using advanced camera and computer technology.